TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Cannabis Stocks
What to Know About Canadian Cannabis Stocks for 2025
Dividend Stocks
Short Selling on the TSX: The Stocks Investors are Betting Against
Cannabis Stocks
Pot Stocks: Buy, Sell, or Hold in 2025?
Cannabis Stocks
Could the Cannabis Bubble Re-Inflate?
Investing
What to Know About Canadian Healthcare Stocks for 2025
Cannabis Stocks
Should You Buy Canopy Growth Stock or Green Thumb Stock Today?
Cannabis Stocks
Are Pot Stocks About to Surge Again?
Cannabis Stocks
Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?
Cannabis Stocks
Can Canopy Growth Stock Finally Recover in 2024?
Cannabis Stocks
I Wouldn’t Touch This TSX Stock With a 60-Foot Pole
Cannabis Stocks
Canopy Growth: Buy, Sell, or Hold?